© 1992 Oxford University Press
other |
Markers of Risk of Asthma Death or Readmission in the 12 Months Following a Hospital Admission for Asthma
Department of Medicine. Wellington School of Medicine PO Box 7343. Wellington. New Ztaland
Crane J (Department of Medicine, Wellington School of Medicine, PO Box 7343, Wellington, New Zealand), Pearce N, Burgess C, Woodman K, Robson B and Beasley R. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. International Journal of Epidemiology 1992; 21: 737–744.
A case-control study has previously been reported of asthma deaths in people aged 5–45 years who had a hospital admission for asthma (the index admission) in New Zealand during 191–1987. The study has been re-analysed to examine the association between markers of asthma severity and risk of asthma death or hospital admission; patients prescribed fenoterol were excluded from this re-analysis because of the previously reported interaction between fenoterol, asthma severity, and asthma deaths. The re-analysis included 39 patients who died of asthma during the 12 months after their index admission, 226 patients who had a readmission for asthma during the 12 months after their index admission, and controls chosen from all index admissions. An admission in the previous 12 months was the strongest marker of subsequent risk of death (odds ratio (OR) = 3.5,95% confidence interval (CI): 1.8–6.9, P < 0.01), and was also a strong marker of subsequent risk of readmission (OR = 3.0, 95% CI: 2.1–4.2, P < 0.01); the risk increased with the number of previous admissions. Three or more categories of prescribed asthma drugs wrrs also associated with subsequent death (OR = 1.7,95% CI: 0.9–3.3, P = 0.13) or readmission (OR = 1.9,95% CI: 1.3–2.7, P < 0.01); prescribed oral corticosteroids was only weakly associated with subsequent death (OR = 1.3,95% CI: 0.6–2.8, P = 0.69), but was more strongly associated with subsequent readmission (OR = 1.9, 95% CI: 1.2–2.8, PPPP < 0.01). Of the four markers of acute asthma severity, (arterial carbon dioxide tension [PCO2], plasma potassium [K+], forced expiratory volume in 1 second [FEV1], peak expiratory flow rate [PEFR]) a PEFR < 100 l/min carrid a 2-fold risk of subsequent death or readmission, and a PCO2 
45 mm Hg was associated with an increased risk of death (but not of readmission). Prescription of psychotropic drugs was atso associated with an increased risk of death (but not of readmission). These findings indicate that the most valid and reliable marker of risk of asthma death or readmission is the number of hospital admissions for asthma in the previous 12 months.
Received 1 February 1992
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Wijesinghe, M. Weatherall, K. Perrin, M. Harwood, and R. Beasley Risk of mortality associated with formoterol: a systematic review and meta-analysis Eur. Respir. J., October 1, 2009; 34(4): 803 - 811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Beasley, F. D. Martinez, A. Hackshaw, K. F. Rabe, P. J. Sterk, and R. Djukanovic Safety of long-acting {beta}-agonists: urgent need to clear the air remains Eur. Respir. J., January 1, 2009; 33(1): 3 - 5. [Full Text] [PDF]
|
|
|
|
|
|
M. R. Sears, A. Ottosson, F. Radner, and S. Suissa Long-acting {beta}-agonists: a review of formoterol safety data from asthma clinical trials Eur. Respir. J., January 1, 2009; 33(1): 21 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Wijesinghe, K Perrin, M Harwood, M Weatherall, and R Beasley The risk of asthma mortality with inhaled long acting {beta}-agonists Postgrad. Med. J., September 1, 2008; 84(995): 467 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bateman, H. Nelson, J. Bousquet, K. Kral, L. Sutton, H. Ortega, and S. Yancey Meta-analysis: Effects of Adding Salmeterol to Inhaled Corticosteroids on Serious Asthma-Related Events Ann Intern Med, July 1, 2008; 149(1): 33 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. To, A. Gershon, C. Wang, S. Dell, and L. Cicutto Persistence and Remission in Childhood Asthma: A Population-Based Asthma Birth Cohort Study Arch Pediatr Adolesc Med, December 1, 2007; 161(12): 1197 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Erickson, C. Iribarren, I. V. Tolstykh, P. D. Blanc, and M. D. Eisner Effect of Race on Asthma Management and Outcomes in a Large, Integrated Managed Care Organization Arch Intern Med, September 24, 2007; 167(17): 1846 - 1852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Aldington and R. Beasley Asthma exacerbations {middle dot} 5: Assessment and management of severe asthma in adults in hospital Thorax, May 1, 2007; 62(5): 447 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Miller, J. H. Lee, P. D. Blanc, D. J. Pasta, S. Gujrathi, H. Barron, S. E. Wenzel, S. T. Weiss, and for the TENOR Study Group TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma Eur. Respir. J., December 1, 2006; 28(6): 1145 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Calfee, P. P. Katz, E. H. Yelin, C. Iribarren, and M. D. Eisner The influence of perceived control of asthma on health outcomes. Chest, November 1, 2006; 130(5): 1312 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Galant, T. Morphew, S. Amaro, and O. Liao Current Asthma Guidelines May Not Identify Young Children Who Have Experienced Significant Morbidity Pediatrics, April 1, 2006; 117(4): 1038 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J R Smith, S Mildenhall, M J Noble, L Shepstone, M Koutantji, M Mugford, and B D W Harrison The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes Thorax, December 1, 2005; 60(12): 1003 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Paasche-Orlow, K. A. Riekert, A. Bilderback, A. Chanmugam, P. Hill, C. S. Rand, F. L. Brancati, and J. A. Krishnan Tailored Education May Reduce Health Literacy Disparities in Asthma Self-Management Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 980 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Krishnan, K. A. Riekert, J. V. McCoy, D. Y. Stewart, S. Schmidt, A. Chanmugam, P. Hill, and C. S. Rand Corticosteroid Use after Hospital Discharge among High-risk Adults with Asthma Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1281 - 1285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. McFadden Jr. Acute Severe Asthma Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 740 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Bloomberg, K. M. Trinkaus, E. B. Fisher Jr., J. R. Musick, and R. C. Strunk Hospital Readmissions for Childhood Asthma: A 10-Year Metropolitan Study Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1068 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P M Sturdy, C R Victor, H R Anderson, J M Bland, B K Butland, B D W Harrison, C Peckitt, and J C Taylor Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study Thorax, December 1, 2002; 57(12): 1034 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Suissa, P Ernst, and A Kezouh Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma Thorax, October 1, 2002; 57(10): 880 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Sin and S. F. P. Man Low-Dose Inhaled Corticosteroid Therapy and Risk of Emergency Department Visits for Asthma Arch Intern Med, July 22, 2002; 162(14): 1591 - 1595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.D. Sin and J.V. Tu Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics Eur. Respir. J., March 1, 2001; 17(3): 380 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. ABRAMSON, M. J. BAILEY, F. J. COUPER, J. S. DRIVER, O. H. DRUMMER, A. B. FORBES, J. J. MCNEIL, E. HAYDN WALTERS, and the Victorian Asthma Mortality Are Asthma Medications and Management Related to Deaths from Asthma? Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 12 - 18. [Abstract] [Full Text]
|
|
|
|
 |
|
 Management of patients with asthma in the emergency department and in hospital Can. Med. Assoc. J., November 1, 1999; 161(90111): s53 - 59. [Full Text]
|
|
|
|
|
|
J. C. C. M.i.`t VEEN, H. H. SMITS, P. S. HIEMSTRA, A. E. ZWINDERMAN, P. J. STERK, and E. H. BEL Lung Function and Sputum Characteristics of Patients with Severe Asthma During an Induced Exacerbation by Double-Blind Steroid Withdrawal Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 93 - 99. [Abstract] [Full Text]
|
|
|
|
|
|
T. HAAHTELA and T. KLAUKKA Societal and health care benefits of early use of inhaled steroids Thorax, December 1, 1998; 53(12): 1005 - 1006. [Full Text]
|
|
|
|
|
|
L. Blais, S. Suissa, J.-F. Boivin, and P. Ernst First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma Thorax, December 1, 1998; 53(12): 1025 - 1029. [Abstract] [Full Text]
|
|
|
|
 |
|
 B D Pethica, A Penrose, D MacKenzie, J Hall, R Beasley, and M Tilyard Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records BMJ, October 10, 1998; 317(7164): 986 - 990. [Abstract] [Full Text]
|
|
|
|
|
|
L. BLAIS, P. ERNST, J.-F. BOIVIN, and S. SUISSA Inhaled Corticosteroids and the Prevention of Readmission to Hospital for Asthma Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 126 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Sherman and C. L. Capen The Red Alert Program for Life-threatening Asthma Pediatrics, August 1, 1997; 100(2): 187 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K S Joseph, L. Blais, P. Ernst, and S. Suissa Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers BMJ, January 13, 1996; 312(7023): 79 - 81. [Abstract] [Full Text]
|
|